These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 3489069)
21. Development of new pharmacological approaches in Parkinson's disease. Carlsson A Adv Neurol; 1987; 45():513-8. PubMed ID: 3493631 [No Abstract] [Full Text] [Related]
25. Glutamic acid decarboxylase mRNA expression in medial and lateral pallidal neurons in the MPTP-treated monkey and patients with Parkinson's disease. Herrero MT; Levy R; Ruberg M; Javoy-Agid F; Luquin MR; Agid Y; Hirsch EC; Obeso JA Adv Neurol; 1996; 69():209-16. PubMed ID: 8615130 [No Abstract] [Full Text] [Related]
26. [MPTP: a new chapter in the history of Parkinson's disease]. Piccinin GL; Piccirilli M; Finali G; Stefano E Riv Neurol; 1989; 59(3):103-7. PubMed ID: 2688042 [TBL] [Abstract][Full Text] [Related]
27. [Parkinson's disease; etiology and animal model]. Mizuno Y No To Shinkei; 1991 Aug; 43(8):703-11. PubMed ID: 1931253 [No Abstract] [Full Text] [Related]
28. Parkinson's disease: current view. Langston JW Am Fam Physician; 1987 Mar; 35(3):201-6. PubMed ID: 3103408 [TBL] [Abstract][Full Text] [Related]
29. [Parkinsonism and MPTP (methylphenyltetrahydropyridine)]. Nagatsu T No To Shinkei; 1986 Jul; 38(7):706-7. PubMed ID: 3489476 [No Abstract] [Full Text] [Related]
30. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) is N-demethylated by cytochromes P450 2D6, 1A2 and 3A4--implications for susceptibility to Parkinson's disease. Coleman T; Ellis SW; Martin IJ; Lennard MS; Tucker GT J Pharmacol Exp Ther; 1996 May; 277(2):685-90. PubMed ID: 8627546 [TBL] [Abstract][Full Text] [Related]
31. [Aging and Parkinson's disease]. Tohgi H; Abe T; Takahashi S No To Shinkei; 1991 Aug; 43(8):713-9. PubMed ID: 1931254 [No Abstract] [Full Text] [Related]